Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individual Treatment of COVID-19 by Application of Alpha-1-antitrypsin

NCT04799873 is registered in ClinicalTrials.gov with Universität des Saarlandes as lead sponsor.

NCT NCT04799873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04799873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individual Treatment of COVID-19 by Application of Alpha-1-antitrypsin
Lead sponsor
Universität des Saarlandes
Phase
Observational
Overall status
Completed
Start date
April 8, 2020
Completion date
December 1, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19